Udruženje kardiologa u BiH

web stranica udruženja kardiologa u Bosni i Hercegovini

Hypercoagulability in COVID-19 and post-COVID patients – characteristics and current treatment guidelines

Evropsko Udruženje Kardiologa (eng. European Society of Cardiology), je u svom glasilu “e-Journal of Cardiology Practice” objavilo rad Doc.dr. Edina Begića, Prof.dr. Nabil Nasera i mr.sci.dr. Nedima Begića.

 

Rad pod naslovom “ Hypercoagulability in COVID-19 and post-COVID patients – characteristics and current treatment guidelines” ukazuje na značaj upotrebe antikoagulacione i antiagregantne terapije tokom COVID-19, stavlja fokus na farmakološke osobine upotrebe određene supstance, te potencira značaj optimiziranog doziranja. Opisane su i indikacije za posthospitalnu upotrebu antikoagulantne terapije, a sami rad daje i osvrt na dijagnostički modalitet kardiovaskularnih komplikacija koje su vezane za COVID-19.

 

Hypercoagulability in COVID-19 and post-COVID patients – characteristics and current treatment guidelines

 

https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-21/hypercoagulability-in-covid-19-and-post-covid-patients-characteristics-and-cur